CN104634982B - Vegf-c在制备败血症及重症细菌感染诊断试剂中的用途 - Google Patents
Vegf-c在制备败血症及重症细菌感染诊断试剂中的用途 Download PDFInfo
- Publication number
- CN104634982B CN104634982B CN201310548097.5A CN201310548097A CN104634982B CN 104634982 B CN104634982 B CN 104634982B CN 201310548097 A CN201310548097 A CN 201310548097A CN 104634982 B CN104634982 B CN 104634982B
- Authority
- CN
- China
- Prior art keywords
- vegf
- septicemia
- bacterial infections
- diagnosis
- serious bacterial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/26—Infectious diseases, e.g. generalised sepsis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310548097.5A CN104634982B (zh) | 2013-11-06 | 2013-11-06 | Vegf-c在制备败血症及重症细菌感染诊断试剂中的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310548097.5A CN104634982B (zh) | 2013-11-06 | 2013-11-06 | Vegf-c在制备败血症及重症细菌感染诊断试剂中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104634982A CN104634982A (zh) | 2015-05-20 |
CN104634982B true CN104634982B (zh) | 2016-08-17 |
Family
ID=53213956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310548097.5A Active CN104634982B (zh) | 2013-11-06 | 2013-11-06 | Vegf-c在制备败血症及重症细菌感染诊断试剂中的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104634982B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111208305B (zh) * | 2020-02-16 | 2023-04-25 | 重庆翼锋生物科技有限公司 | Hbp和pct在败血症诊断试剂制备中的用途 |
CN114184693B (zh) * | 2021-10-14 | 2023-10-13 | 重庆医科大学 | 4-羟苯乙酸作为标志物在制备脓毒症脑病的诊断试剂盒中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101299962A (zh) * | 2004-12-15 | 2008-11-05 | 貝丝以色列女执事医疗中心 | 可用于诊断和治疗妊娠并发症的核酸和多肽 |
WO2011020115A2 (en) * | 2009-08-14 | 2011-02-17 | Allergan, Inc. | Methods of treating cancer using growth factor retargeted endopeptidases |
CN102028935A (zh) * | 2009-09-29 | 2011-04-27 | 上海南方基因科技有限公司 | 败血症以及败血症休克的预测、预防和治疗方法及试剂盒 |
JP5828849B2 (ja) * | 2010-03-02 | 2015-12-09 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 無症候性患者における全身性炎症反応症候群およびセプシスの早期診断および予測に基づくil−6の検出 |
WO2012096245A1 (ja) * | 2011-01-11 | 2012-07-19 | 三菱化学メディエンス株式会社 | 敗血症の予後の予測方法 |
-
2013
- 2013-11-06 CN CN201310548097.5A patent/CN104634982B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104634982A (zh) | 2015-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Monastero et al. | Cytokines as biomarkers and their respective clinical cutoff levels | |
Chang et al. | Chikungunya arthritis mechanisms in the Americas: a cross‐sectional analysis of chikungunya arthritis patients twenty‐two months after infection demonstrating no detectable viral persistence in synovial fluid | |
Lu et al. | Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis | |
Endo et al. | Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: a multicenter prospective study | |
Ibrahim et al. | Diagnostic value of serum procalcitonin levels in children with meningitis: a comparison with blood leukocyte count and C-reactive protein | |
Sakurai et al. | Positioning and usefulness of biomarkers in inflammatory bowel disease | |
Summah et al. | Biomarkers: a definite plus in pneumonia | |
Li et al. | Association of circulating follicular helper T cells with disease course of NMO spectrum disorders | |
CN103869086A (zh) | 一种血清自身抗体检测试剂盒 | |
Wagatsuma et al. | Role of biomarkers in the diagnosis and treatment of inflammatory bowel disease | |
CN102081101A (zh) | 用于在急性中风或暂时性缺血性发作的患者中诊断细菌感染和指导抗生素治疗的降钙素原 | |
Zhou et al. | Combined CD25, CD64, and CD69 biomarker panel for flow cytometry diagnosis of sepsis | |
Attar et al. | Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites | |
Papadopoulos et al. | Assessment of interleukins IL-4, IL-6, IL-8, IL-10 in acute urticaria | |
Cabré et al. | Evaluation of CONUT for clinical malnutrition detection and short-term prognostic assessment in hospitalized elderly people | |
Herberth et al. | Identification of a molecular profile associated with immune status in first-onset schizophrenia patients | |
Xu et al. | Predictive value of combined LIPS and ANG‐2 level in critically ill patients with ARDS risk factors | |
Parenica et al. | Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality | |
Chen et al. | Utility of sTREM-1 and Presepsin (sCD14-ST) as Diagnostic and Prognostic Markers of Sepsis. | |
CN101010589A (zh) | 阿尔茨海默病的生物标记 | |
CN111602057A (zh) | 使用降钙素原和中区肾上腺髓质素原的风险评估和患者管理的工作流程 | |
CN104634982B (zh) | Vegf-c在制备败血症及重症细菌感染诊断试剂中的用途 | |
CN106526196B (zh) | Sr-a作为类风湿关节炎诊断标志物及干预靶点的应用 | |
Mezher et al. | Analysis of proinflammatory cytokines in COVID-19 patients in Baghdad, Iraq | |
Wen et al. | Retracted: Effects of S100A12 gene silencing on serum levels of anti‐inflammatory/pro‐inflammatory cytokines in septic rats through the ERK signaling pathway |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Hongyan Inventor after: Zhang Yanbo Inventor after: Lu Yao Inventor after: Ma Li Inventor after: Wei Bin Inventor before: Wang Hongyan |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200430 Address after: 200031 building 35, No. 320, Yueyang Road, Xuhui District, Shanghai Patentee after: Center for excellence and innovation of molecular cell science, Chinese Academy of Sciences Address before: 200031 No. 320, Yueyang Road, Shanghai, Xuhui District Patentee before: SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES |
|
TR01 | Transfer of patent right |